Immunotherapy on Neurodegenarative Diseases: Mini Review

Authors

  • Kishor Danao Dadasaheb Balpande College of Pharmacy, Besa, Nagpur (MS) 440037
  • Kailash Jatwe Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Besa, Nagpur
  • Ujwala Mahajan Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Besa, Nagpur

DOI:

https://doi.org/10.7439/ijpr.v9i11.5340

Keywords:

Alzheimer's disease, pathophysiology, Immunotherapy

Abstract

Neurodegenerative disease is a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias). Neurodegenerative diseases (NDs) have a serious impact on global health with no effective treatments available to date. Vaccination has been proposed as a therapeutic approach for NDs, and clinical evaluations of some candidates for Alzheimer's disease and multiple sclerosis are ongoing. Moreover, monoclonal antibodies for passive immunotherapy are under evaluation for Common Neurodegenarative diseases such as Alzheimer

Downloads

Download data is not yet available.

Downloads

Published

2019-11-30

Issue

Section

Review Article

How to Cite

1.
Danao K, Jatwe K, Mahajan U. Immunotherapy on Neurodegenarative Diseases: Mini Review. Int J of Pharmc Res [Internet]. 2019 Nov. 30 [cited 2025 Mar. 14];9(11):e5340. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/5340